Safety and Immunogenicity of Two Doses of H5N1 Influenza Vaccine in Healthy Adults

NCT01776541 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

979

Enrollment

INDUSTRY

Sponsor class

Conditions

Pandemic H5N1 Influenza

Interventions

BIOLOGICAL: Adjuvanted H5N1 pandemic influenza vaccine

Sponsor

Novartis Vaccines

Collaborators

[object Object]